![Office of Translational Sciences 2022 Annual Report](https://public4.pagefreezer.com:443/content/FDA/06-07-2023T01:12/https://www.fda.gov/files/styles/medium_3/public/OTS-2022-AR_1600x900_230615.jpg?itok=ONt6RvO4)
CDER’s Office of Translational Sciences publishes 2022 Annual Report
June 30 - Report offers new insights into science, research, regulation and more
June 30 - Report offers new insights into science, research, regulation and more
June 26 - Safe disposal is one part of FDA’s effort to address overdose crisis
June 13 - Learn about program initiatives to drive rare disease drug development
June 12 - FC is a common condition experienced by children and adolescents
June 6 - Guidance ensures participant safety and reliability of clinical trials
May 31 - These recommendations can improve detection of treatment effects
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.